Trial · NCT01061736
Participant flow50
How many started, completed or left each group, period by period.
1 to 20 of 50
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Part A: SAR 100 mg qw | 50 | |
| Overall Study | STARTED | Part A: SAR 150 mg qw | 50 | |
| Overall Study | STARTED | Part A: SAR 100 mg q2w | 51 | |
| Overall Study | STARTED | Part A: SAR 150 mg q2w | 51 | |
| Overall Study | STARTED | Part A: SAR 200 mg q2w | 52 | |
| Overall Study | STARTED | Part A: Placebo qw | 52 | |
| Overall Study | STARTED | Part B Cohort 1: Non-selected Doses | 84 | |
| Overall Study | STARTED | Part B: SAR 150 mg q2w (Cohort 1 [Selected Dose]+Cohort 2) | 430 | |
| Overall Study | STARTED | Part B: SAR 200 mg q2w (Cohort 1 [Selected Dose]+Cohort 2) | 427 | |
| Overall Study | STARTED | Part B: Placebo q2w (Cohort 1[Selected Dose]+Cohort 2) | 428 | |
| Overall Study | Treated | Part A: SAR 100 mg qw | 50 | |
| Overall Study | Treated | Part A: SAR 150 mg qw | 50 | |
| Overall Study | Treated | Part A: SAR 100 mg q2w | 51 | |
| Overall Study | Treated | Part A: SAR 150 mg q2w | 51 | |
| Overall Study | Treated | Part A: SAR 200 mg q2w | 51 | |
| Overall Study | Treated | Part A: Placebo qw | 52 | |
| Overall Study | Treated | Part B Cohort 1: Non-selected Doses | 84 | |
| Overall Study | Treated | Part B: SAR 150 mg q2w (Cohort 1 [Selected Dose]+Cohort 2) | 428 | |
| Overall Study | Treated | Part B: SAR 200 mg q2w (Cohort 1 [Selected Dose]+Cohort 2) | 426 | |
| Overall Study | Treated | Part B: Placebo q2w (Cohort 1[Selected Dose]+Cohort 2) | 428 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01061736/flow